NDC 55150-430 – Tirofiban
Tirofiban Hydrochloride 12.5 mg/250mL · Injection, Solution · Intravenous
Product NDC55150-430
Product details
- Brand name
- Tirofiban
- Generic name
- Tirofiban
- Labeler
- Eugia US LLC
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA216379
- Marketed since
- May 1, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Platelet Aggregation Inhibitor
Active ingredients
- Tirofiban Hydrochloride 12.5 mg/250mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 55150-430-01 | 1 POUCH in 1 CARTON (55150-430-01) / 1 BAG in 1 POUCH / 250 mL in 1 BAG | May 1, 2023 |
Recalls mentioning this NDC
- D-0390-2025 May 7, 2025 · Class II
Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances. - D-0389-2025 May 7, 2025 · Class II
Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.
Other Tirofiban products
- 55150-429 Tirofiban Hydrochloride 5 mg/100mL · Injection, Solution · Eugia US LLC